{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,4,28]],"date-time":"2023-04-28T13:40:41Z","timestamp":1682689241361},"reference-count":23,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2004,4,28]],"date-time":"2004-04-28T00:00:00Z","timestamp":1083110400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clin Rheumatol"],"published-print":{"date-parts":[[2004,12]]},"DOI":"10.1007\/s10067-004-0924-5","type":"journal-article","created":{"date-parts":[[2004,4,27]],"date-time":"2004-04-27T06:40:28Z","timestamp":1083048028000},"page":"485-489","source":"Crossref","is-referenced-by-count":7,"title":["Diagnostic performance of anti-\u03b22 glycoprotein I and anticardiolipin assays for clinical manifestations of the antiphospholipid syndrome"],"prefix":"10.1007","volume":"23","author":[{"given":"Mittermayer","family":"Santiago","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Reinaldo","family":"Martinelli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mitermayer G.","family":"Reis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eliana Almeida","family":"Reis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Albert","family":"Ko","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roberto Dias","family":"Fontes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Moacir Paranhos","family":"Silva","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eliane Goes","family":"Nascimento","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rog\u00e9rio","family":"de Jesus","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Silvia","family":"Pierangeli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ricardo","family":"Espinola","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Azzudin","family":"Gharavi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2004,4,28]]},"reference":[{"key":"CR1","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1055\/s-0028-1142018","volume":"32","author":"Wassermman","year":"1906","unstructured":"Wassermman A, Neisser A, Bruck C (1906) Eine serodiagnostische Reaktion bei Syphilis. Dtsch Med Wochenschr 32:745?746","journal-title":"Dtsch Med Wochenschr"},{"key":"CR2","doi-asserted-by":"crossref","first-page":"484","DOI":"10.3181\/00379727-48-13365P","volume":"48","author":"Pangborn","year":"1941","unstructured":"Pangborn MC (1941) A new serologically active phospholipid from beef heart. Proc Soc Exp Biol Med 48:484?486","journal-title":"Proc Soc Exp Biol Med"},{"key":"CR3","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1001\/jama.1952.03680050033010","volume":"150","author":"Moore","year":"1952","unstructured":"Moore JE, Mohr CF (1952) Biologically false positive serologic tests for syphilis. JAMA 150:467?473","journal-title":"JAMA"},{"key":"CR4","first-page":"621","volume":"31","author":"Conley","year":"1952","unstructured":"Conley CL, Hartmann RC (1952) A hemorrhagic disorder caused by circulating anticoagulants in patients with disseminated lupus erythematosus. J Clin Invest 31:621?622","journal-title":"J Clin Invest"},{"key":"CR5","first-page":"75","volume":"1","author":"Feinstein","year":"1972","unstructured":"Feinstein DI, Rapaport SI (1972) Acquired inhibitors of blood coagulation. Prog Hemostasis Thromb 1:75?95","journal-title":"Prog Hemostasis Thromb"},{"key":"CR6","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1172\/JCI109869","volume":"66","author":"Thiagarajan","year":"1980","unstructured":"Thiagarajan P, Shapiro SS, DeMarco L (1980) A monoclonal IgM coagulation inhibitor with phospholipid specificity. Mechanism of a lupus anticoagulant. J Clin Invest 66:397?405","journal-title":"J Clin Invest"},{"key":"CR7","doi-asserted-by":"crossref","first-page":"2153","DOI":"10.1001\/archinte.1986.00360230069012","volume":"146","author":"Harris","year":"1986","unstructured":"Harris EN, Chan JKH, Asherson RA, Aber VE, Gharavi AE, Hughes GRV (1986) Thrombosis, recurrent fetal loss, and thrombocytopenia. Predictive value of the anticardiolipin antibody test. Arch Intern Med 146:2153?2156","journal-title":"Arch Intern Med"},{"key":"CR8","first-page":"486","volume":"13","author":"Hughes","year":"1986","unstructured":"Hughes GRV, Harris EN, Gharavi AE (1986) The antiphospholipid syndrome. J Rheumatol 13:486?489","journal-title":"J Rheumatol"},{"key":"CR9","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1002\/1529-0131(199907)42:7<1309::AID-ANR1>3.0.CO;2-F","volume":"42","author":"Wilson","year":"1999","unstructured":"Wilson WA, Gharavi AE, Koike T, Lockshin MD, Branch DW, Piette JC, et al. (1999) International consensus statement on preliminary classification criteria for definite antiphospholipid syndrome: report of an international workshop. Arthritis Rheum 42:1309?1311","journal-title":"Arthritis Rheum"},{"key":"CR10","doi-asserted-by":"crossref","first-page":"1544","DOI":"10.1016\/0140-6736(90)91374-J","volume":"336","author":"Galli","year":"1990","unstructured":"Galli M, Comfurius P, Maassen C, Hemker HC, De Baets MH, Van Breda-Vriesman PJC, et al. (1990) Anticardiolipin antibodies (ACA) directed not to cardiolipin but to a plasma protein cofactor. Lancet 336:1544?1547","journal-title":"Lancet"},{"key":"CR11","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/0140-6736(90)91697-9","volume":"336","author":"Matsuura","year":"1990","unstructured":"Matsuura E, Igarashi Y, Fujimoto M, Ichikawa K, Koike T (1990) Anticardiolipin cofactor (s) and differential diagnosis of autoimmune disease. Lancet 336:177?178","journal-title":"Lancet"},{"key":"CR12","doi-asserted-by":"crossref","first-page":"4120","DOI":"10.1073\/pnas.87.11.4120","volume":"87","author":"McNeil","year":"1990","unstructured":"McNeil HP, Simpson RJ, Chesterman CN, Krilis S (1990) Antiphospholipid antibodies are directed against a complex antigen that includes a lipid-binding inhibitor of coagulation: ?-2-glycoprotein I (apolipoprotein H). Proc Natl Acad Sci U S A 87:4120?4124","journal-title":"Proc Natl Acad Sci U S A"},{"key":"CR13","first-page":"1899","volume":"22","author":"Cabiedes","year":"1995","unstructured":"Cabiedes J, Cabral AR, Alarc\ufffdn-Seg\ufffdvia D (1995) Clinical manifestations of the antiphospholipid syndrome in patients with systemic lupus erythematosus associate more strongly with anti-?-2-glycoprotein I than with antiphospholipid antibodies. J Rheumatol 22:1899?1906","journal-title":"J Rheumatol"},{"key":"CR14","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1111\/j.1365-2141.1995.tb03317.x","volume":"89","author":"Martinuzzo","year":"1995","unstructured":"Martinuzzo ME, Forastiero RR, Carreras LO (1995) Anti ?-2-glycoprotein I antibodies: detection and association with thrombosis. Br J Haematology 89:397?402","journal-title":"Br J Haematology"},{"key":"CR15","first-page":"1894","volume":"22","author":"Cabral","year":"1995","unstructured":"Cabral AR, Cabiedes J, Alarc\ufffdn-Segovia D (1995) Antibodies to phospholipid-free ?2-Glycoprotein-I in patients with primary antiphospholipid syndrome. J Rheumatol 22:1894?1898","journal-title":"J Rheumatol"},{"key":"CR16","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1046\/j.1365-2249.1997.4601357.x","volume":"109","author":"Guerin","year":"1997","unstructured":"Guerin J, Feighery C, Sim RB, Jackson J (1997) Antibodies to beta2-glycoprotein I: a specific marker for the antiphospholipid syndrome. Clin Exp Immunol 109:304?309","journal-title":"Clin Exp Immunol"},{"key":"CR17","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1002\/art.1780251101","volume":"25","author":"Tan","year":"1982","unstructured":"Tan EM, Cohen AS, Fries JF, Masi AT, McShane DJ, Rothfield NF, et al. (1982) The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 25:1271?1277","journal-title":"Arthritis Rheum"},{"key":"CR18","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1016\/0020-711X(84)90168-X","volume":"16","author":"Wurm","year":"1984","unstructured":"Wurm H (1984) Beta 2-Glycoprotein-I (apolipoprotein H) interactions with phospholipid vesicles. Int J Biochem 16:511?515","journal-title":"Int J Biochem"},{"key":"CR19","doi-asserted-by":"crossref","first-page":"954","DOI":"10.4049\/jimmunol.154.2.954","volume":"154","author":"Roubey","year":"1995","unstructured":"Roubey RA, Eisenberg RA, Harper MF, Winfield JB (1995) ?Anticardiolipin? autoantibodies recognize beta 2-glycoprotein I in the absence of phospholipid. Importance of Ag density and bivalent binding. J Immunol 154:954?960","journal-title":"J Immunol"},{"key":"CR20","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1136\/ard.46.1.1","volume":"46","author":"Gharavi","year":"1987","unstructured":"Gharavi AE, Harris EN, Asherson RA, Hughes GRV (1987) Antiphospholipid antibodies: isotype distribution and phospholipid specificity. Ann Rheum Dis 46:1?6","journal-title":"Ann Rheum Dis"},{"key":"CR21","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1016\/S0022-2143(97)90004-4","volume":"129","author":"Sanmarco","year":"1997","unstructured":"Sanmarco M, Soler C, Christides C (1997) Prevalence and clinical significance of IgG isotype anti-beta 2-glycoprotein I antibodies in antiphospholipid syndrome: a comparative study with anticardiolipin antibodies. J Lab Clin Med 129:499?506","journal-title":"J Lab Clin Med"},{"key":"CR22","first-page":"37","volume":"28","author":"Santiago","year":"1988","unstructured":"Santiago MB, Bueno C, Viana VST, Yoshinari NH, Cossermelli W, Oliveira RM (1988) Anticorpos anticardiolipina em l\ufffdpus eritematoso sist\ufffdmico (LES). Rev Bras Reumatol 28:37?42","journal-title":"Rev Bras Reumatol"},{"key":"CR23","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1007\/BF02030510","volume":"9","author":"Costallat","year":"1990","unstructured":"Costallat LTL, Oliveira RM, Santiago MB, Cossermelli W, Samara AM (1990) Neuropsychiatric manifestations of systemic lupus erythematosus: the value of anticardiolipin, antigangliosides and antigalactocerebrosides antibodies. Clin Rheumatol 9:489?497","journal-title":"Clin Rheumatol"}],"container-title":["Clinical Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-004-0924-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10067-004-0924-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-004-0924-5","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,4,28]],"date-time":"2023-04-28T13:15:33Z","timestamp":1682687733000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10067-004-0924-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,4,28]]},"references-count":23,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2004,12]]}},"alternative-id":["924"],"URL":"https:\/\/doi.org\/10.1007\/s10067-004-0924-5","relation":{},"ISSN":["0770-3198","1434-9949"],"issn-type":[{"value":"0770-3198","type":"print"},{"value":"1434-9949","type":"electronic"}],"subject":[],"published":{"date-parts":[[2004,4,28]]}}}